{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pre-conception-advice-management/management/advice-for-all-women/","result":{"pageContext":{"chapter":{"id":"eb9c8dbd-e2aa-5e1d-ad75-0f16e58a1422","slug":"advice-for-all-women","fullItemName":"Scenario: Advice for all women","depth":2,"htmlHeader":"<!-- begin field 6851a66c-142e-41fe-973d-56f421f80364 --><h2>Scenario: Pre-conception advice for all women</h2><!-- end field 6851a66c-142e-41fe-973d-56f421f80364 -->","summary":"Covers general advice on pre-conception care that is applicable to all women who are planning a pregnancy.","htmlStringContent":"<!-- begin item a3e9fc5c-40f9-4604-9280-805e131e958c --><!-- begin field 76efcead-530c-4ca0-9ddd-acbd00863c77 --><p>From age 16 years to 45 years (Female).</p><!-- end field 76efcead-530c-4ca0-9ddd-acbd00863c77 --><!-- end item a3e9fc5c-40f9-4604-9280-805e131e958c -->","topic":{"id":"7fbac536-1f76-5678-a8d3-791cde12bdcc","topicId":"362122fc-a8d4-48c6-bbe1-260b84fdc035","topicName":"Pre-conception - advice and management","slug":"pre-conception-advice-management","lastRevised":"Last revised in November 2019","chapters":[{"id":"b4e662d9-e04d-5220-9289-f9d2f83a655d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d516f1b7-0d03-56d1-a1ff-98ee4586d10c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"05f2e291-0cb3-508a-a53a-203bf7452154","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"eea0164e-7605-53f2-82b1-30649c6b462b","slug":"changes","fullItemName":"Changes"},{"id":"3107f6a6-010e-5793-b49e-f188321b5d25","slug":"update","fullItemName":"Update"}]},{"id":"ccdc8c20-befb-5b1b-9e44-e7d66512c304","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d2c77d6a-aa8b-5f5a-bc22-e802a1ed63dd","slug":"goals","fullItemName":"Goals"},{"id":"354ac657-195c-55c7-86dc-32bd495719e6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"90c0a8b7-d685-5b54-ab19-50262a840059","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8991e1d6-fe99-54e2-a7f0-8c087cbc913e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ce6a54cd-7770-5f7d-b3d4-72d82e13e288","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"cea8adf5-cc1a-59e9-b1bc-a7fe7dd9612e","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8ebfaff6-f12e-5e6d-a4da-824f9755cc22","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"eb257b56-0f26-5b88-b016-779a5c57372a","slug":"definition","fullItemName":"Definition"}]},{"id":"cb07c890-793e-585a-b84c-853632ed27ce","fullItemName":"Management","slug":"management","subChapters":[{"id":"bd42d278-6050-5b5b-866a-cbfbf0423199","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"eb9c8dbd-e2aa-5e1d-ad75-0f16e58a1422","slug":"advice-for-all-women","fullItemName":"Scenario: Advice for all women"},{"id":"7e7545d6-d6f7-57bc-89ea-6441a4ec2db1","slug":"mental-health-problems","fullItemName":"Scenario: Mental health problems"},{"id":"1a2f1279-2d58-50c7-9319-7566398adf95","slug":"chronic-medical-conditions","fullItemName":"Scenario: Chronic medical conditions"},{"id":"06434a48-ae53-5381-a6e0-d1d478bf119e","slug":"genetic-risk-assessment","fullItemName":"Scenario: Genetic risk assessment"}]},{"id":"09ba2cc8-ed92-569e-8221-2fc8961a9165","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5d207bb7-2d21-5faf-8689-655bc58b847f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5c10ffbd-047a-5920-9dc4-cfc597cebbad","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"aaed13a3-4796-527d-97c1-0d3f0522735c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d4f44dbc-1899-520a-af01-19a4c31b4859","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"78c00268-d8ca-507c-b64e-d937902ec290","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8a776444-784a-5839-9597-61faaeeb2101","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6a3cee62-2ded-5f48-b3fc-9b11a7a28a12","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"cb07c890-793e-585a-b84c-853632ed27ce","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"22244537-e008-5a64-84d1-7e10d4b6b386","slug":"advice-on-timing-of-pregnancy","fullItemName":"Advice on timing of pregnancy","depth":3,"htmlHeader":"<!-- begin field 44d72083-92e5-4495-b247-a7a500c9c2e6 --><h3>What advice can I give a woman about the timing of pregnancy?</h3><!-- end field 44d72083-92e5-4495-b247-a7a500c9c2e6 -->","summary":null,"htmlStringContent":"<!-- begin item 55b5b52e-5287-4a65-bf62-a7a500c9c098 --><!-- begin field 0a229d87-8881-49a3-9dab-a7a500c9c2e6 --><ul><li><strong>Discuss the potential impact of maternal age on fertility and birth outcomes. </strong><strong> </strong><ul><li>Women over 35 years have an increased risk of miscarriage, chromosomal abnormalities, and obstetric complications compared with younger women.</li></ul></li><li><strong>Discuss interpregnancy interval</strong> (the time from delivery of one child to conception of the next).<ul><li>There is evidence to suggest that an interpregnancy interval of 18–59 months is safer in terms of perinatal outcomes, but the decision should take into account the woman's individual circumstances (for example a shorter interpregnancy interval may be appropriate for older women concerned about age-related decline in fertility). </li></ul></li><li><strong>If the woman has had a previous miscarriage, discuss that there is no definite 'right time' to start trying to conceive again. </strong>The decision will be influenced by a number of factors including when the woman and her partner feel ready; speed of physical recovery; and whether the woman is awaiting test results or being followed up after surgery, or ectopic or molar pregnancy.<ul><li>Patient information is available from the Royal College of Obstetricians and Gynaecologists (<a href=\"https://www.rcog.org.uk/en/patients/patient-leaflets/early-miscarriage/\" data-hyperlink-id=\"0b358aaa-f4e9-4400-a52e-a93100bb22a2\">Early Miscarriage</a>, available at <a href=\"https://www.rcog.org.uk/\" data-hyperlink-id=\"63fa59b6-c592-4d27-9392-a93100bb22ed\">www.rcog.org.uk</a>). This provides information for women who have experienced first-trimester pregnancy loss and includes information about trying for another baby.</li><li>For more information on miscarriage and when to refer women who have experienced recurrent miscarriage for investigation, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/miscarriage/\">Miscarriage</a>.</li></ul></li></ul><!-- end field 0a229d87-8881-49a3-9dab-a7a500c9c2e6 --><!-- end item 55b5b52e-5287-4a65-bf62-a7a500c9c098 -->","subChapters":[{"id":"4e7c84d9-d62c-51e7-b98b-3541e26fcda8","slug":"basis-for-recommendation-f43","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 330ab348-4799-4d47-818b-a7a500c9c2ea --><h4>Basis for recommendation</h4><!-- end field 330ab348-4799-4d47-818b-a7a500c9c2ea -->","summary":null,"htmlStringContent":"<!-- begin item f432aecf-9219-4611-9ae0-a7a500c9c2ea --><!-- begin field 6d00ca8b-4508-4ab6-9f4e-a7a500c9c2ea --><h5>Maternal age</h5><ul><li>This recommendation is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Callegari et al, 2015</a>]<strong> </strong>and is extrapolated from the results of an analysis of prospective data from 36,056 women to identify effects of maternal age on obstetric outcomes. This mentioned the association between increasing maternal age and subfertility and found an increased risk of miscarriage, chromosomal abnormalities, congenital abnormalities, gestational diabetes, placenta praevia, and caesarian delivery in women aged over 35 years, with women over 40 years experiencing an increased risk of abruption, preterm delivery, low birth weight and perinatal mortality<strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Cleary-Goldman et al, 2005</a>].</li></ul><h5>Interpregnancy interval</h5><ul><li>This recommendation is based on a position statement from the American Academy of Family Physicians [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>]<strong> </strong>and evidence from a meta-analysis of data from cohort, cross-sectional, and case-control studies looking at the association between birth spacing and adverse perinatal outcomes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Conde-Agudelo et al, 2006</a>].</li></ul><h5>Miscarriage</h5><ul><li>This recommendation is based on patient information, produced by the Royal College of Obstetricians and Gynaecologists Patient Information Committee [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">RCOG, 2016a</a>]<strong> </strong>and the Miscarriage Association [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Miscarriage Association, 2013</a>].</li></ul><!-- end field 6d00ca8b-4508-4ab6-9f4e-a7a500c9c2ea --><!-- end item f432aecf-9219-4611-9ae0-a7a500c9c2ea -->","subChapters":[]}]},{"id":"4969a587-c232-5c17-824f-3f1168ff0bd8","slug":"advice-on-conception","fullItemName":"Advice on conception","depth":3,"htmlHeader":"<!-- begin field 14044c6a-ddaf-48d1-91d8-5543579ff792 --><h3>What advice can I give a woman about conception?</h3><!-- end field 14044c6a-ddaf-48d1-91d8-5543579ff792 -->","summary":null,"htmlStringContent":"<!-- begin item 5d6f9453-d8cb-4f56-ad3f-68b6be4c26f2 --><!-- begin field e33ddc3e-c97b-455d-9af4-46a316e4b378 --><ul><li>Advise that:<ul><li>Of 100 couples (in which the woman is aged under 40 years) having regular sexual intercourse without contraception: <ul><li>More than 80 will conceive within 1 year.</li><li>About half of those who do not conceive in the first year will do so in the second year.</li></ul></li><li>The remainder will take longer and some of these may need help for them to conceive. </li></ul></li><li>Advise that sexual intercourse every 2 to 3 days optimises the chances of pregnancy. <ul><li>There is no need to plan intercourse to coincide with ovulation — this does not increase the chances of success and can cause stress for the couple.<strong> </strong></li></ul></li><li>The Family Planning Association (FPA) produces a leaflet, <em>Planning a Pregnancy</em>, to explain how a woman can prepare for a pregnancy, how conception occurs, and how she and her partner can improve her chances of getting pregnant (available at <a href=\"http://www.fpa.org.uk/help-and-advice/planning-pregnancy\" data-hyperlink-id=\"cf628d61-49e7-4e2b-8f78-a93100c683a0\">www.fpa.org.uk</a>).</li><li>Advise women planning pregnancy who have been using the progestogen-only injection for contraception that normal fertility may be delayed for up to 1 year after the last injection. </li><li>For further information about what to do if a couple is having difficulty conceiving see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/infertility/\">Infertility</a>.</li></ul><!-- end field e33ddc3e-c97b-455d-9af4-46a316e4b378 --><!-- end item 5d6f9453-d8cb-4f56-ad3f-68b6be4c26f2 -->","subChapters":[{"id":"b1f3fec1-7bb4-50b4-9b09-907ecd46226b","slug":"basis-for-recommendation-6db","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a3424ff7-8939-47a8-ad61-aead5365d651 --><h4>Basis for recommendation</h4><!-- end field a3424ff7-8939-47a8-ad61-aead5365d651 -->","summary":null,"htmlStringContent":"<!-- begin item 6dbfcd4a-f05e-4b68-b9b1-d41e208ffc5b --><!-- begin field 5a35623d-e0fe-44e9-abe3-0e86f15e2c56 --><h5>Conception statistics</h5><ul><li>The figures about the time taken for 100 couples to conceive are derived from statistics quoted by the National Institute for Health and Care Excellence (NICE) in their guideline on <em>Fertility problems: assessment and treatment</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2013</a>].</li></ul><h5>Optimising the chances of pregnancy</h5><ul><li>This recommendation is based on the NICE guideline <em>Fertility problems: assessment and treatment</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2013</a>].<strong> </strong>Expert opinion in a review article does not suggest planning intercourse to coincide with ovulation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Seshadri et al, 2012</a>]. </li></ul><h5>Delayed fertility with the progestogen-only injection</h5><ul><li>The advice about the delay to normal fertility with injected progestogen only contraception is derived from evidence reported by the National Institute for Health and Care Excellence in the guideline <em>Long-acting reversible contraception</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2005</a>].</li></ul><!-- end field 5a35623d-e0fe-44e9-abe3-0e86f15e2c56 --><!-- end item 6dbfcd4a-f05e-4b68-b9b1-d41e208ffc5b -->","subChapters":[]}]},{"id":"2928ca5a-17e3-5856-98ee-47a27b371cb3","slug":"advice-on-folic-acid","fullItemName":"Advice on folic acid","depth":3,"htmlHeader":"<!-- begin field ff538ba6-01d8-402f-8805-d97e3f19a2f2 --><h3>What advice should I give a woman planning pregnancy regarding folic acid?</h3><!-- end field ff538ba6-01d8-402f-8805-d97e3f19a2f2 -->","summary":null,"htmlStringContent":"<!-- begin item 3de5205b-b615-4990-a9f8-dd313c908fbd --><!-- begin field 360fbda7-6e2b-4bc8-9e6c-87776b880f2f --><ul><li><strong>Assess the couple's risk of a neural tube defect (NTD)</strong>.<ul><li>Couples are at high risk of conceiving a child with an NTD if:<ul><li>Either partner has an NTD, they have had a previous pregnancy affected by an NTD, or they have a family history of an NTD. </li><li>The woman is taking anti–epileptic medication.</li><li>The woman has diabetes mellitus<strong>, </strong>sickle cell anaemia, or thalassaemia. </li><li>The woman is obese (defined as a body mass index [BMI] of 30 kg/m<sup>2</sup>or more).</li></ul></li></ul></li><li><strong>Advise women who are at normal risk for an NTD </strong>to take folic acid 400 micrograms daily, and once pregnant, to continue this until the twelfth week of pregnancy.<strong> </strong></li><li><strong>Advise women at high risk of an NTD </strong>to take folic acid 5 mg daily and, once pregnant, to continue this until the twelfth week of pregnancy. <ul><li>Women with sickle cell disease, thalassaemia, or thalassaemia trait should take folic acid 5 mg daily throughout pregnancy.</li></ul></li></ul><!-- end field 360fbda7-6e2b-4bc8-9e6c-87776b880f2f --><!-- end item 3de5205b-b615-4990-a9f8-dd313c908fbd -->","subChapters":[{"id":"a697e723-1964-54da-8c35-85731dce5633","slug":"basis-for-recommendation-fed","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c872d70f-a341-452b-a2a8-717a453feb3d --><h4>Basis for recommendation</h4><!-- end field c872d70f-a341-452b-a2a8-717a453feb3d -->","summary":null,"htmlStringContent":"<!-- begin item fed56ec6-896b-4c72-9b9f-258556cd08a4 --><!-- begin field ee4d1a35-79be-4cef-8582-205997f4c3c0 --><h5>Risk of neural tube defect</h5><ul><li>Assessing the couple's risk of conceiving a child with a neural tube defect (NTD) allows an appropriate dose of folic acid to be given, depending on the level of risk. The information on factors and conditions increasing the risk of a neural tube defect is based on UK guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2012a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">RCOG, 2011a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">RCOG, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">SIGN, 2015</a>], reports [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>],<strong> </strong>an analysis from the UK Teratology Information Service [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UKTIS, 2011a</a>], and a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>].</li></ul><h5>Recommending folic acid supplements to all women</h5><ul><li>There is compelling evidence in a Cochrane systematic review that examined the effect of folic acid on the incidence of NTDs. The meta-analysis of five good-quality studies included 6708 women and found that folic acid supplementation in women who became pregnant or were less than 12 weeks pregnant at the time of the study reduced the incidence of NTDs (RR 0.31, 95% CI 0.17 to 0.58) compared with no intervention, placebo, or other micronutrients without folate. The authors concluded that 'folic acid, alone or in combination with vitamins and minerals, prevents NTDs but does not have a clear effect on other birth defects' [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">De-Regil et al, 2015</a>].</li></ul><h5>Dose of folate supplementation depending on the risk of NTD</h5><ul><li>The recommendation to prescribe folic acid 5 mg daily to people at higher risk of an NTD and 400 micrograms to people at normal risk of NTD is based on the recommendations of an expert advisory group in 1992 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Expert Advisory Group et al, 1992</a>], and reiterated by NICE in the guideline: <em>Antenatal care for uncomplicated pregnancies</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2008a</a>]; and reports from the National Institute for Health Research (NIHR): <em>Better beginnings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>] and the Parliamentary Office of Science and Technology: <em>Dietary advice, pregnancy and breastfeeding</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>], which references this document: <a href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/338892/SACN_Folate_and_Disease_Prevention_Report.pdf\" data-hyperlink-id=\"6cb491eb-eb5d-4455-95b5-aab900bc839e\">SACN Folate and Disease Prevention Report 2006</a> and advice in the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BNF 73, 2017</a>]. </li></ul><h5>High dose folic acid supplements throughout pregnancy in women with haemoglobinopathies</h5><ul><li>This recommendation is based on expert opinion in the Royal College of Obstetricians and Gynaecologists (RCOG) guideline <em>Management of sickle cell disease in pregnancy</em> that recommends that, to prevent neural tube defects, women with sickle cell disease should receive folic acid 5 mg once daily pre-conceptually and during pregnancy because of the increased demand for folate in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">RCOG, 2011a</a>].<strong> </strong>This is supported by advice in the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BNF 73, 2017</a>].</li><li>For women with thalassaemia, the RCOG guideline <em>Management of beta thalassaemia in pregnancy</em> recommends a dose of 5 mg folic acid daily, to start 3 months before conception. This dose reduces the risk of neural tube defects as the demand for folic acid is higher in women with thalassaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">RCOG, 2014</a>]. Expert opinion in a review article also recommends folic acid supplementation before and during pregnancy for women with thalassaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Lao, 2017</a>]. Haemolysis is a predominant feature of haemoglobin H disease (three absent alpha globin genes) and is exacerbated by pregnancy, so experts recommend prophylactic folic acid 5 mg daily [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Clark et al, 2012</a>]. </li><li>Women with thalassemia trait are anaemic because erythropoiesis is ineffective. The increased turnover in the bone marrow results in folate depletion. Expert advice in a textbook suggests that these women will probably benefit from taking 5 mg of folic acid daily throughout pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Strong and Rutherford, 2011</a>].</li></ul><!-- end field ee4d1a35-79be-4cef-8582-205997f4c3c0 --><!-- end item fed56ec6-896b-4c72-9b9f-258556cd08a4 -->","subChapters":[]}]},{"id":"50e3a26f-ebaa-5f3c-b2c5-d9c964e62cff","slug":"advice-on-diet","fullItemName":"Advice on diet","depth":3,"htmlHeader":"<!-- begin field 3b0f7132-c5a4-4065-bcb7-a7a500b60549 --><h3>What advice should I give on diet?</h3><!-- end field 3b0f7132-c5a4-4065-bcb7-a7a500b60549 -->","summary":null,"htmlStringContent":"<!-- begin item ebaf3309-ac55-41c9-b5a0-a7a500b6037a --><!-- begin field 0fc234ee-ce89-45de-8a4d-a7a500b60549 --><ul><li>Advise women considering pregnancy to eat a healthy, balanced diet. </li><li>To maintain a healthy weight before pregnancy, women should: <ul><li>Base meals on starchy food (for example bread, rice, pasta, potatoes), choosing wholegrain if possible.</li><li>Eat fibre-rich foods (for example fruit, vegetables, oats, beans, peas, lentils).</li><li>Eat at least 5 portions of different fruits and vegetables each day.</li><li>Eat a low-fat diet.</li><li>Eat as little as possible of fried food, drinks and confectionary with added sugar (for example cakes, fizzy drinks), and other foods high in fat and sugar.</li><li>Eat breakfast.</li><li>Be aware of portion sizes of meals and snacks and how often they eat.</li></ul></li><li>The <a href=\"https://www.gov.uk/government/publications/the-eatwell-guide\" data-hyperlink-id=\"b5b64081-cc40-4a49-91f5-a93100ad8944\">Eatwell Guide</a> provides information on how to achieve a balance of healthier food.</li><li>For advice on diet and foods to avoid in pregnancy see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/antenatal-care-uncomplicated-pregnancy/\">Antenatal care - uncomplicated pregnancy</a>.</li></ul><!-- end field 0fc234ee-ce89-45de-8a4d-a7a500b60549 --><!-- end item ebaf3309-ac55-41c9-b5a0-a7a500b6037a -->","subChapters":[{"id":"2f04844a-a44c-5e15-b943-067f95957b4f","slug":"basis-for-recommendation-428","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 828a5499-d22e-44c0-a0c4-a7a500b6054e --><h4>Basis for recommendation</h4><!-- end field 828a5499-d22e-44c0-a0c4-a7a500b6054e -->","summary":null,"htmlStringContent":"<!-- begin item 4285262c-38a2-4893-ab22-a7a500b6054e --><!-- begin field f7cc978d-d82c-4d66-906e-a7a500b6054e --><h5>Advice to women planning pregnancy to eat a healthy, balanced diet</h5><ul><li>CKS recommends a healthy, balanced diet for women planning to conceive based on expert opinion in reports from the National Institute for Health Research Dissemination Centre: <em>Better beginnings, improving health for pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>],<strong> </strong>the Parliamentary Office of Science and Technology: <em>Dietary advice, pregnancy and breastfeeding </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>] and NHS Greater Glasgow and Clyde (public health) <em>Prepared for pregnancy? Preconception health, education and care in Scotland</em>  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Sher, 2016</a>]. Expert opinion in review articles has also been taken into account [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Seshadri et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Ioannides, 2017</a>]. <ul><li>Diet and nutrition before conception and during pregnancy are important as it can impact on pregnancy outcomes and the health of the mother and her baby [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>].</li></ul></li></ul><h5>Dietary advice to help maintain a healthy weight before pregnancy</h5><ul><li>This recommendation is based on the National Institute for Health and Clinical Excellence public health guideline <em>Weight management before, during and after pregnancy</em><strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2010a</a>].</li></ul><h5>Using the Eatwell guide for information on achieving a balance of healthier food</h5><ul><li>The report from the National Institute for Health Research Dissemination Centre: <em>Better beginnings, improving health for pregnancy </em>recommends the Eatwell guide for this purpose [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>].</li></ul><!-- end field f7cc978d-d82c-4d66-906e-a7a500b6054e --><!-- end item 4285262c-38a2-4893-ab22-a7a500b6054e -->","subChapters":[]}]},{"id":"5445306f-8902-5e91-a9a6-ad2ed6c968bd","slug":"advice-on-weight-management","fullItemName":"Advice on weight management","depth":3,"htmlHeader":"<!-- begin field d81d24e9-60e0-4349-82dc-a7a500b63cb3 --><h3>What should I advise on weight management?</h3><!-- end field d81d24e9-60e0-4349-82dc-a7a500b63cb3 -->","summary":null,"htmlStringContent":"<!-- begin item 6c9917df-c11f-47dd-8490-a7a500b63a83 --><!-- begin field ca005192-3b8e-4e1c-a0e0-a7a500b63cb3 --><ul><li>Advise women that achieving a healthy weight (BMI 18.5–24.9 kg/m<sup>2</sup>) before becoming pregnant reduces the risk of pregnancy complications. </li><li>Advise the woman of the potential health risks of being obese (BMI of 30 kg/m<sup>2 </sup>or more) including: <ul><li>Reduced fertility. </li><li>Increased risk of miscarriage. </li><li>Gestational diabetes.</li><li>Gestational hypertension/pre-eclampsia. </li><li>Macrosomia and shoulder dystocia.</li><li>Preterm delivery.</li><li>Birth trauma.</li><li>Caesarean delivery.</li><li>Postpartum complications (for example haemorrhage, thrombosis and infection).</li><li>Stillbirth.</li><li>Congenital anomalies (for example neural tube defects, cardiovascular anomalies, cleft palate, limb reduction, anorectal atresia, hydrocephaly).</li></ul></li><li>Advise and encourage women who are obese (BMI of 30 kg/m<sup>2</sup> or more) to lose weight before becoming pregnant. <ul><li>Women should be informed that losing 5–10% of their weight (a realistic target) would have significant health benefits and could increase their chances of becoming pregnant. </li><li>Women should be encouraged to check their weight and waist measurement periodically, or as an alternative, check the fit of their clothes. </li><li>Offer a weight loss support programme that includes advice about diet and physical activity.</li><li>Women should be aware that if they do become pregnant, there is no need to 'eat for two' or to drink full-fat milk. </li></ul></li><li>Advise women who are obese (BMI of 30 kg/m<sup>2</sup> or more) to take folic acid 5 mg daily starting at least one month before conception and continuing during the first trimester.</li><li>Advise women with a low BMI (less than 18.5 kg/m<sup>2</sup>) of the potential health risks of being underweight, including: <ul><li>Reduced fertility.</li><li>First-trimester miscarriage.</li><li>Preterm birth. </li><li>Low birth weight. </li><li>Gastroschisis. </li></ul></li><li>If an eating disorder is suspected, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eating-disorders/\">Eating disorders</a>. </li></ul><!-- end field ca005192-3b8e-4e1c-a0e0-a7a500b63cb3 --><!-- end item 6c9917df-c11f-47dd-8490-a7a500b63a83 -->","subChapters":[{"id":"04984b1e-af80-5cf5-bf35-7a25170f7d11","slug":"basis-for-recommendation-540","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2ef6ef5e-d788-4761-8a1b-a7a500b63cb8 --><h4>Basis for recommendation</h4><!-- end field 2ef6ef5e-d788-4761-8a1b-a7a500b63cb8 -->","summary":null,"htmlStringContent":"<!-- begin item 540e7bc1-5357-40de-9b09-a7a500b63cb8 --><!-- begin field 1b7b7e34-63a4-4f49-a5dc-a7a500b63cb8 --><h5>Advice on achieving a healthy weight before conception</h5><ul><li>This recommendation is based on a National Institute for Health Research (NIHR) report: <em>Better beginnings, improving health for pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>], a Parliamentary Office of Science and Technology report: <em>Dietary advice, pregnancy and breastfeeding </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>].</li></ul><h5>Risks of being overweight before conception</h5><ul><li>The recommendation to advise women of the potential health risks of obesity is based on the National Institute for Health and Care Excellence (NICE) public health guideline <em>Weight management before, during and after pregnancy </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2010a</a>], the American Academy of Family Physicians (AAFP) guideline <em>Preconception care</em> (position paper) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Callegari et al, 2015</a>]. </li><li>Examples of health risks of being obese have been collated from a number of sources: a NIHR report <em>Better beginnings, improving health for pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>]; reports on <em>Dietary advice, pregnancy and breastfeeding </em>from the Parliamentary Office of Science and Technology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>] and obesity, reproduction and pregnancy outcomes from the Academy of Nutrition and Dietetics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Stang and Huffman, 2016</a>]; an AAFP position statement on <em>Preconception care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>]; a UKTIS monograph on <em>Obesity in pregnancy </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UKTIS, 2011a</a>]; and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BMJ Best Practice, 2016</a>].</li></ul><h5>Weight loss</h5><ul><li>The recommendation to advise women to lose weight if obese, and the target weight loss suggested is based on the NICE public health guidance: <em>Weight management before, during and after pregnancy </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2010a</a>]. </li><li>The recommendation to offer a weight loss support programme is based on expert opinion in the NICE public health guidance: <em>Weight management before, during and after pregnancy </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2010a</a>] and a report on obesity, reproduction and pregnancy outcomes from the Academy of Nutrition and Dietetics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Stang and Huffman, 2016</a>].<ul><li>Although a Cochrane systematic review found no randomised controlled trials assessing the effect of preconception interventions on pregnancy outcomes for overweight or obese women [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Opray et al, 2015</a>], a NIHR report: <em>Better beginnings, improving health for pregnancy</em> was of the opinion that women in these groups could benefit from accessing general weight management services [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>]. </li></ul></li><li>The dietary advice if a woman becomes pregnant is based on the fact that energy needs do not change in the first 6 months of pregnancy, and in the last 3 months of pregnancy, they increase slightly by approximately 200 calories per day [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2010a</a>].</li></ul><h5>Folic acid</h5><ul><li>A woman with a body mass index of 30 kg/m<sup>2</sup> or more is considered to be at high risk of conceiving a child with a neural tube defect [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UKTIS, 2011a</a>] and the recommended dose of folic acid for women at high risk is 5 mg once daily, to be continued until the twelfth week of pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2008a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BNF 73, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>].</li></ul><h5>Risk of being underweight before conception</h5><ul><li>The recommendation to advise women of the potential risks of being underweight before conception, and the examples of health risks of being underweight are based on the AAFP guideline <em>Preconception care</em> (position paper) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>],<strong>  </strong>a NIHR report <em>Better beginnings, improving health for pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>].</li></ul><h5>Suspected eating disorder</h5><ul><li>The recommendation on suspected eating disorders is extrapolated from a NIHR report <em>Better beginnings, improving health for pregnancy</em> which suggests that specialist monitoring and support are required for women with eating disorders in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>].</li></ul><!-- end field 1b7b7e34-63a4-4f49-a5dc-a7a500b63cb8 --><!-- end item 540e7bc1-5357-40de-9b09-a7a500b63cb8 -->","subChapters":[]}]},{"id":"ad51571b-f090-52a8-aff4-a054475a489c","slug":"advice-on-smoking","fullItemName":"Advice on smoking","depth":3,"htmlHeader":"<!-- begin field add6259b-7adb-4fad-828b-5da1d227f15c --><h3>What advice should I give to a woman planning pregnancy who smokes?</h3><!-- end field add6259b-7adb-4fad-828b-5da1d227f15c -->","summary":null,"htmlStringContent":"<!-- begin item 96bb76b5-6448-474e-9899-a14dfb97c0ec --><!-- begin field b9427671-19db-4633-a7b8-cdb88bc01ae3 --><ul><li><strong>Advise all women planning pregnancy who smoke to stop smoking.</strong><ul><li>Offer women who wish to stop smoking referral to a smoking-cessation service.</li><li>Advise women who may become pregnant to initially try to stop smoking without using nicotine replacement therapy (NRT).</li><li>Consider offering NRT to women who are planning a pregnancy, and who have tried and failed to stop smoking without using NRT.</li></ul></li><li>Do not prescribe bupropion or varenicline to women who may become pregnant.</li><li>For further information about how to manage a woman who wishes to stop smoking see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/smoking-cessation/\">Smoking cessation</a>.</li></ul><!-- end field b9427671-19db-4633-a7b8-cdb88bc01ae3 --><!-- end item 96bb76b5-6448-474e-9899-a14dfb97c0ec -->","subChapters":[{"id":"349ae850-3de1-5110-9658-4d5ec8511bad","slug":"basis-for-recommendation-206","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 530929cb-d8fc-4706-ad04-33a73d1a2c10 --><h4>Basis for recommendation</h4><!-- end field 530929cb-d8fc-4706-ad04-33a73d1a2c10 -->","summary":null,"htmlStringContent":"<!-- begin item 206713e0-0a08-434c-b922-6e09646f30c0 --><!-- begin field 781407d7-2877-4c39-8403-4a4dd5b00ddd --><h5>Advising women who smoke and wish to become pregnant to stop smoking</h5><ul><li>CKS recommends women planning a pregnancy stop smoking, because smoking in pregnancy is harmful to the mother, fetus, and others at home [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Schaefer, 2015</a>]. Tobacco smoking in pregnancy has been linked with complications including spontaneous abortion, intrauterine growth retardation, cleft lip and palate, preterm birth, placental abruption, stillbirth, and sudden infant death syndrome (SIDS) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UKTIS, 2011b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>]. Completing smoking cessation before pregnancy reduces the greatest modifiable risk for adverse pregnancy outcomes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>].</li><li>This recommendation is supported by reports from the National Institute for Health Research (NIHR) <em>Better beginnings, improving health for pregnancy</em>  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>]<strong> </strong>and NHS Greater Glasgow and Clyde (public health) <em>Prepared for pregnancy? Preconception health, education and care in Scotland </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Sher, 2016</a>];<strong> </strong>the American Academy of Family Physicians (AAFP) position paper <em>Preconception care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>];<strong> </strong>a fact sheet from the US Centers for Disease Control and Prevention on Preconception clinical care for women: Exposures [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>]; and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Callegari et al, 2015</a>]. </li></ul><h5>Referral to a smoking-cessation service</h5><ul><li>The National Institute for Health and Care Excellence (NICE) public health guideline on <em>Stop smoking services</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2008b</a>]<strong> </strong>recommends that:<ul><li>At consultations, primary healthcare professionals should advise all smokers to quit. Those who want to quit should be referred to an intensive support service such as the NHS Stop Smoking Services, and those who are unwilling or unable to be referred should be offered drug treatment and additional support.</li><li>Smokers wishing to quit should receive behavioural therapy, advice, and support (with or without pharmacological treatment) from a healthcare professional trained to provide smoking cessation services.</li></ul></li><li>The US Centers for Disease Control and Prevention also recommend brief interventions for women of childbearing age who are smokers, followed by referral to a more intensive service if the woman wishes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>].<strong> </strong></li><li>A Cochrane systematic review (search date November 2015) found that psychosocial interventions such as counselling can increase the proportion of women stopping smoking in late pregnancy and low birthweight newborns, but the role of health education remains unclear [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Chamberlain et al, 2017</a>]. </li></ul><h5>Initially trying to stop smoking without using NRT</h5><ul><li>This recommendation for women planning a pregnancy is extrapolated from expert opinion that suggests that where possible, smoking cessation during pregnancy should use non-pharmacological methods such as counselling or behavioural therapies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UKTIS, 2011b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Schaefer, 2015</a>]. </li></ul><h5>Offering NRT to women who have tried and failed to stop smoking without using NRT</h5><ul><li>This recommendation is extrapolated from expert opinion for pregnant women that, if non-pharmacological measures for smoking cessation fail, nicotine replacement therapy can be considered, using professional judgement, if it will reduce the mother's tobacco use and therefore exposure to the fetus [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2008a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UKTIS, 2011b</a>]. With nicotine replacement therapy, the exposure is to nicotine alone, compared with the many chemicals found in tobacco smoke (for example carbon monoxide, hydrocarbons, and tar) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UKTIS, 2011b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Schaefer, 2015</a>].</li></ul><h5>Not prescribing bupropion or varenicline for women who may become pregnant</h5><ul><li>This recommendation is extrapolated from the NICE public health guideline on <em>Stop smoking services</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2008b</a>]. <ul><li>There are a lack of data available on the safety of these drugs during pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Schaefer, 2015</a>]. If bupropion or varenicline is prescribed, the course should be completed before the woman tries to conceive as these drugs should not be offered to pregnant women<strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BNF 73, 2017</a>].</li></ul></li></ul><!-- end field 781407d7-2877-4c39-8403-4a4dd5b00ddd --><!-- end item 206713e0-0a08-434c-b922-6e09646f30c0 -->","subChapters":[]}]},{"id":"705bfbbe-230c-5b49-a14a-9db3db9ad3f0","slug":"advice-about-alcohol-consumption","fullItemName":"Advice about alcohol consumption","depth":3,"htmlHeader":"<!-- begin field 05b68a0e-d4c4-4bed-98c9-a429a5fdac04 --><h3>What advice should I give to a women planning pregnancy, regarding alcohol consumption?</h3><!-- end field 05b68a0e-d4c4-4bed-98c9-a429a5fdac04 -->","summary":null,"htmlStringContent":"<!-- begin item d3372b6b-b8c7-4e62-8493-91e9c827a4f7 --><!-- begin field 97ae222d-0e35-49b2-8ded-1da0470b56ed --><ul><li>Advise women planning pregnancy (or who are at any stage of pregnancy) to avoid drinking alcohol. <ul><li>For further information on how to provide advice and support for a person who wishes to reduce their drinking, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/alcohol-problem-drinking/\">Alcohol - problem drinking</a>.</li></ul></li><li>Offer specialist referral if a women is unable to reduce her drinking with support in primary care.</li></ul><!-- end field 97ae222d-0e35-49b2-8ded-1da0470b56ed --><!-- end item d3372b6b-b8c7-4e62-8493-91e9c827a4f7 -->","subChapters":[{"id":"2a8c5389-fc2b-559e-a56c-8a1ad6cf23aa","slug":"basis-for-recommendation-ad0","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4d8b6c59-edf4-45b8-b277-07dbb83e7f35 --><h4>Basis for recommendation</h4><!-- end field 4d8b6c59-edf4-45b8-b277-07dbb83e7f35 -->","summary":null,"htmlStringContent":"<!-- begin item ad0c62fc-7eaa-4f63-8016-bec658705197 --><!-- begin field 000649ec-c260-4c7c-a9f2-016c79e87bde --><h5>Avoidance of alcohol if trying to conceive</h5><ul><li>The recommendation for women to avoid alcohol if they are pregnant or trying to conceive is based on the Chief Medical Officers' <em>Low risk drinking guidelines</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">DH, 2016</a>]. The aim of this advice is to keep fetal risks to a minimum and is supported by a British Medical Association report <em>Alcohol and pregnancy. Preventing and managing fetal alcohol spectrum disorders </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BMA, 2016</a>];<strong> </strong>a<strong> </strong>National Institute for Health Research (NIHR) report: <em>Better beginnings, improving health for pregnancy </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>];<strong> </strong>a<strong> </strong>Parliamentary Office of Science and Technology report: <em>Dietary advice, pregnancy and breastfeeding </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">POST, 2017</a>]; a NHS Greater Glasgow and Clyde (public health) report <em>Prepared for pregnancy? Preconception health, education and care in Scotland</em><strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Sher, 2016</a>]; and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Seshadri et al, 2012</a>].</li><li>Although the risk of harm to the baby is likely to be low if a woman has drunk only small amounts of alcohol before she was aware of her pregnancy, it is safest for a woman not to drink alcohol if she is pregnant or could become pregnant [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">DH, 2016</a>].<ul><li>Risks to a baby from alcohol use in pregnancy include fetal alcohol spectrum disorders (FASD) and fetal alcohol syndrome, characterised by reduced growth, facial abnormalities, and potentially long-term learning and behavioural difficulties [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">DH, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>].</li><li>Preterm birth and babies that are of low birth weight and small for gestational age may also be more common in mothers drinking more than 1–2 units of alcohol per day during pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">DH, 2016</a>]. </li></ul></li></ul><h5>Referral</h5><ul><li>The British Medical Association report on <em>Alcohol and pregnancy. Preventing and managing fetal alcohol spectrum disorders</em> gives referral to specialist alcohol services as an example of a specific prevention strategy for high-risk women [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BMA, 2016</a>]. Expert opinion in a review article on preconception counselling and care also advises referral for women with alcohol dependence [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>].</li></ul><!-- end field 000649ec-c260-4c7c-a9f2-016c79e87bde --><!-- end item ad0c62fc-7eaa-4f63-8016-bec658705197 -->","subChapters":[]}]},{"id":"3cf6a630-8583-5caa-906a-c1e608adc77e","slug":"advice-on-illicit-drug-use","fullItemName":"Advice on illicit drug use","depth":3,"htmlHeader":"<!-- begin field 42800651-68ba-4db0-9f2f-50e1328750c6 --><h3>What advice should I give to a woman planning pregnancy, who uses illicit drugs?</h3><!-- end field 42800651-68ba-4db0-9f2f-50e1328750c6 -->","summary":null,"htmlStringContent":"<!-- begin item 3e531814-e303-4395-b210-e29f910e6543 --><!-- begin field c3ee81c9-165f-4a0e-95d5-98d9b69bc2d3 --><ul><li>Advise women planning pregnancy who use illicit drugs to stop using drugs (including so-called 'legal highs'), if they are able to do so.<ul><li>For more information about managing women who are dependent on opioids, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/opioid-dependence/\">Opioid dependence</a>.</li></ul></li><li>Offer women planning pregnancy who use illicit drugs and are unable to stop with support in primary care referral to a specialist service.</li><li>Offer contraceptive advice to women using illicit drugs who may become pregnant before illicit drug use has stopped.<ul><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>.</li></ul></li><li>Offer women injecting illicit drugs testing for hepatitis B, hepatitis C, and HIV.<ul><li>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>.</li></ul></li></ul><!-- end field c3ee81c9-165f-4a0e-95d5-98d9b69bc2d3 --><!-- end item 3e531814-e303-4395-b210-e29f910e6543 -->","subChapters":[{"id":"9a8ec177-58be-522e-ad48-0ea52fa19392","slug":"basis-for-recommendation-145","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 11200b14-37b3-4901-bfd6-6e11107ab062 --><h4>Basis for recommendation</h4><!-- end field 11200b14-37b3-4901-bfd6-6e11107ab062 -->","summary":null,"htmlStringContent":"<!-- begin item 1452b2af-5ca6-46ce-8536-c73ff201fcab --><!-- begin field 0f5469bc-07b9-48c6-bdc0-066abf937331 --><h5>Stopping illicit drug use before conception</h5><ul><li>Illicit drug use can be harmful to the health of the woman and her baby and can co-exist with alcohol and smoking which also increase health risks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>].</li><li>A number of studies have reported harms to the fetus from illicit drug use during pregnancy, including [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Shankaran et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Callegari et al, 2015</a>]:<ul><li>Marijuana — possible childhood neurodevelopmental effects (although data are not conclusive).</li><li>Cocaine — low birth weight, small head circumference, premature birth, perinatal death.</li><li>Heroin and other opiates — spontaneous abortion, intrauterine death, low birth weight, premature birth, infant distress due to acute drug withdrawal after delivery.</li></ul></li><li>It is therefore widely recommended by experts that illicit drugs should be avoided by women considering pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Seshadri et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Sher, 2016</a>].</li></ul><h5>Referral for women planning pregnancy who are unable to stop illicit drug use</h5><ul><li>The recommendation to refer women having difficulties with misuse of drugs is based on a National Institute for Health Research report: <em>Better beginnings, improving health for pregnancy</em>, which infers that this group of women may require specialist support and care during pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NIHR, 2017</a>].</li><li>Other organisations supporting this recommendation include the American Academy of Family Physicians, whose position paper on <em>Preconception care </em>advises that family physicians provide women of childbearing age who misuse drugs brief interventions and refer as appropriate to a treatment centre or higher level care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>]<strong>. </strong>The US Centers for Disease Control and Prevention also recommend, as part of a pre-conception risk assessment, referral to a programme providing abstinence support and rehabilitation for women using illicit substances [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>].</li></ul><h5>Offering contraceptive advice</h5><ul><li>This recommendation is based on expert opinion in a factsheet from the Centers for Disease Control and Prevention on <em>Preconception clinical care for women: Exposures</em> which indicates the importance of delaying pregnancy until a woman is free of illicit substances [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>].</li></ul><h5>Hepatitis C, hepatitis B, and HIV testing </h5><ul><li>People who have ever injected drugs are at increased risk of hepatitis B and C. The National Institute for Health and Care Excellence (NICE) public health guideline <em>Hepatitis B and C testing: people at risk of infection</em> recommends that GPs and practice nurses should offer Hepatitis B and C testing to people who currently inject, or have a history of injecting, drugs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2012b</a>]. </li><li>UK National Guidelines for HIV testing state that HIV testing should also be offered to any person with a history of injecting drugs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">BHIVA, 2008</a>]. </li></ul><!-- end field 0f5469bc-07b9-48c6-bdc0-066abf937331 --><!-- end item 1452b2af-5ca6-46ce-8536-c73ff201fcab -->","subChapters":[]}]},{"id":"3038f2c4-b7f2-57e8-92c3-8766410df8bb","slug":"advice-on-hazardous-substances-or-radiation","fullItemName":"Advice on hazardous substances or radiation","depth":3,"htmlHeader":"<!-- begin field f6c1ba0f-2351-4784-8ed5-84041802898c --><h3>What advice should I give to women who are planning pregnancy who may be exposed to hazardous substances or radiation?</h3><!-- end field f6c1ba0f-2351-4784-8ed5-84041802898c -->","summary":null,"htmlStringContent":"<!-- begin item 615abada-d4e1-4cf3-b373-267f30214f09 --><!-- begin field 1ab773d5-2cec-404d-ba6e-7e73d26265c6 --><ul><li>Advise women planning pregnancy to be aware of the potential for exposure to toxic substances in their home, workplace, and surrounding environment and to avoid them if possible.<ul><li>It is possible for chemical exposure to occur through breathing, eating or drinking, or skin absorption. </li></ul></li><li>Advise a woman who is planning pregnancy and is concerned about work exposure to hazardous substances, infections, or radiation, to discuss her intention of becoming pregnant to her employer, if possible.</li><li>Advise a woman planning pregnancy who does not wish to discuss her intention to become pregnant to her employer, that information about the risk of exposure to specific substances can be obtained by contacting an expert at the Health and Safety Executive. Further information is available on the Health and Safety Executive website at <a href=\"http://www.hse.gov.uk/\" data-hyperlink-id=\"fca0b35d-495f-40db-a46a-a93100a03600\">www.hse.gov.uk</a>.</li><li>It may be possible at some work places to have a discussion with an occupational medicine specialist, if this is available. </li></ul><!-- end field 1ab773d5-2cec-404d-ba6e-7e73d26265c6 --><!-- end item 615abada-d4e1-4cf3-b373-267f30214f09 -->","subChapters":[{"id":"31795265-c68a-5be1-8423-247a315115de","slug":"basis-for-recommendation-245","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 738b8da2-0e22-4a2c-8df7-8c006f873b11 --><h4>Basis for recommendation</h4><!-- end field 738b8da2-0e22-4a2c-8df7-8c006f873b11 -->","summary":null,"htmlStringContent":"<!-- begin item 245ff8f1-6c92-4123-b4f8-295777fb3a25 --><!-- begin field 3ef6b5c6-5b98-46a3-9af1-90739ff65668 --><h5>Avoiding exposure to hazardous substances and radiation</h5><ul><li>This recommendation is based on expert opinion that pre-conception care should include alerting women to potential hazards and, if possible, avoiding exposure to toxic substances in the home, environment, and workplace [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Sutton et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Di Renzo et al, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Sher, 2016</a>]. Examples include pesticides, solvents, heavy metals, tobacco smoke<strong>,</strong> carbon monoxide; anaesthetic gases; and ionising radiation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Salihu et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Sutton et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>]. </li><li>In their position paper: <em>Preconception care</em>, the American Academy of Family Physicians notes the importance of addressing occupational hazards and exposures [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>],<strong> </strong>some of which have been linked to adverse reproductive outcomes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>]. There is evidence to suggest that preconception and prenatal exposure to toxins in the environment can significantly affect reproductive health [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">ACOG, 2013</a>].</li></ul><h5>Workplace exposure to hazardous substances and radiation</h5><ul><li>CKS recommends discussing plans for pregnancy with an employer if possible as they are legally obliged to<strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">UK Parliament, 1999</a>]: <ul><li>Ensure that employees are informed of all potential risks to their health and safety.</li><li>Assess the health and safety risks for different groups of employees, including the risks to women of childbearing age who could be in the early stages of pregnancy but unaware that they are pregnant.</li><li>Inform all women of childbearing age of potential hazards in their workplace.</li><li>Implement all reasonable health and safety measures identified by the assessment as being necessary, to remove or reduce the risk to women of childbearing age.</li></ul></li><li>The Health and Safety Executive (<a href=\"http://www.hse.gov.uk/aboutus/insidehse.htm\" data-hyperlink-id=\"1b23568d-6512-4d1b-a827-a93100cd2a6c\">www.hse.gov.uk</a>) is an alternative source of information — as an organisation its role is to prevent ill-health, injury, or death in Great Britain's workplaces.  </li><li>The recommendation to discuss with an occupational medicine specialist, if available, is based on the Centers for Disease Control and Prevention factsheet <em>Preconception clinical care for women: Exposures </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>].</li></ul><!-- end field 3ef6b5c6-5b98-46a3-9af1-90739ff65668 --><!-- end item 245ff8f1-6c92-4123-b4f8-295777fb3a25 -->","subChapters":[]}]},{"id":"1062622c-5ff3-5ad3-a4bd-006bf5f7bd1e","slug":"advice-on-prescription-over-the-counter-medication-herbal-remedies","fullItemName":"Advice on prescription and over-the-counter medication and herbal remedies","depth":3,"htmlHeader":"<!-- begin field 43a0acc4-fa79-46dd-ab3c-a7a500bd143e --><h3>What advice should I give about prescription and over-the-counter medication and herbal remedies?</h3><!-- end field 43a0acc4-fa79-46dd-ab3c-a7a500bd143e -->","summary":null,"htmlStringContent":"<!-- begin item 1317c572-d42e-4024-a195-a7a500bd1298 --><!-- begin field b8b849e7-b2e4-4b98-910c-a7a500bd143e --><ul><li>If the woman is taking prescribed medication, discuss any changes that may need to be made, taking into account:<ul><li>It is important to continue certain drugs (for example if stopping the drug would cause a worsening of the underlying disease that would be considered to be a higher risk to the pregnancy).<strong> </strong></li><li>Some medications are not considered to be safe in pregnancy and may potentially adversely affect the fetus. </li><li>There may be a need to switch to a safer alternative medication before conception. </li><li>Some medications will need to be stopped if they require a washout period before conception.<strong> </strong></li><li>Ideally, the smallest number of medications at the lowest dose possible should be used when trying to conceive. </li></ul></li><li>For more specific information on changes to prescribed medication in the pre-conception period, see the Scenarios on <a class=\"topic-reference internal-reference\" href=\"/topics/pre-conception-advice-management/management/mental-health-problems/\">Mental health issues</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/pre-conception-advice-management/management/chronic-medical-conditions/\">Chronic medical conditions</a>.</li><li>Advise women planning pregnancy not to take any over-the-counter medicines without consulting a pharmacist to ensure that these products are safe to take if she were to become pregnant. </li><li>Advise women planning pregnancy not to take any herbal remedies.</li></ul><!-- end field b8b849e7-b2e4-4b98-910c-a7a500bd143e --><!-- end item 1317c572-d42e-4024-a195-a7a500bd1298 -->","subChapters":[{"id":"994d840e-64d6-5fd9-be43-dd65b6b9c743","slug":"basis-for-recommendation-5a9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1be8bbda-fb86-46d1-8ec4-a7a500bd1442 --><h4>Basis for recommendation</h4><!-- end field 1be8bbda-fb86-46d1-8ec4-a7a500bd1442 -->","summary":null,"htmlStringContent":"<!-- begin item 5a97a426-7172-46ad-8126-a7a500bd1442 --><!-- begin field 0a3faafe-f6ba-4587-8154-a7a500bd1442 --><h5>Discussing changes to prescribed medication</h5><ul><li>This recommendation is intended as a general guide and advice should be tailored to the individual circumstances of the woman. It is based on an American Academy of Family Physicians position paper: <em>Preconception care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>],<strong> </strong>a US Centers for Disease Control and Prevention factsheet on <em>Preconception clinical care for women: Exposures</em><strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>],<strong> </strong>and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Seshadri et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Farahi and Zolotor, 2013</a>].</li></ul><h5>Over-the-counter medication</h5><ul><li>The US Centers for Disease Control and Prevention recommend that women of reproductive age should be encouraged to discuss the use of over-the-counter medication with the provider when planning a pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>].<ul><li>This is because some medications available over the counter (for example ibuprofen, aspirin) should be avoided in pregnancy as they may be harmful to the fetus [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Callegari et al, 2015</a>].</li></ul></li></ul><h5>Herbal remedies</h5><ul><li>CKS does not recommend the use of herbal medicines in women planning pregnancy because evidence on their efficacy, toxicity, and safety is limited [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Schaefer, 2015</a>]. The US Centers for Disease Control and Prevention emphasise the importance of educating women about discussing the use of herbal dietary supplements before pregnancy and making them aware of the unknown safety profile of many products [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">CDC, 2014</a>].</li></ul><!-- end field 0a3faafe-f6ba-4587-8154-a7a500bd1442 --><!-- end item 5a97a426-7172-46ad-8126-a7a500bd1442 -->","subChapters":[]}]},{"id":"aa6db51c-8a33-54ed-8575-f211532aa7f3","slug":"advice-on-cervical-screening","fullItemName":"Advice on cervical screening","depth":3,"htmlHeader":"<!-- begin field b28a5e80-3699-4a70-8199-04021a4eb368 --><h3>What advice should I give a woman who wishes to become pregnant regarding cervical screening?</h3><!-- end field b28a5e80-3699-4a70-8199-04021a4eb368 -->","summary":null,"htmlStringContent":"<!-- begin item 3e4299c3-7253-499a-92e0-54d0ce323004 --><!-- begin field 8c54fe90-9890-473a-b786-b6979be056eb --><ul><li>Advise all women planning pregnancy who are due a cervical smear test to have the test as soon as possible, <em>before </em>becoming pregnant.</li></ul><!-- end field 8c54fe90-9890-473a-b786-b6979be056eb --><!-- end item 3e4299c3-7253-499a-92e0-54d0ce323004 -->","subChapters":[{"id":"5cd8a85e-7d48-52a5-9aad-fac2dfc12811","slug":"basis-for-recommendation-800","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d7a67088-4004-4e6d-ad04-5d4d8cdee42a --><h4>Basis for recommendation</h4><!-- end field d7a67088-4004-4e6d-ad04-5d4d8cdee42a -->","summary":null,"htmlStringContent":"<!-- begin item 8004f4db-4f50-4513-bdc8-96883bdaa96d --><!-- begin field a45da9d8-9b8d-4a80-807b-8956868db4eb --><ul><li>This recommendation is based on guidelines from the NHS cervical screening programme which recommend deferring a routine cervical screening test if the woman is pregnant [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016c</a>].</li></ul><!-- end field a45da9d8-9b8d-4a80-807b-8956868db4eb --><!-- end item 8004f4db-4f50-4513-bdc8-96883bdaa96d -->","subChapters":[]}]},{"id":"f98cf358-6693-5cb6-b47e-603b7c7b01f2","slug":"advice-on-immunizations","fullItemName":"Advice on immunizations","depth":3,"htmlHeader":"<!-- begin field 42b964da-0467-40ea-a90b-aec3eb24fd39 --><h3>What advice should I give women planning pregnancy regarding immunizations?</h3><!-- end field 42b964da-0467-40ea-a90b-aec3eb24fd39 -->","summary":null,"htmlStringContent":"<!-- begin item 70f0c118-a7b1-46d0-a041-7227e35c5b8e --><!-- begin field bc08ad40-64fe-40b3-a06f-373e55ab3e7e --><ul><li><strong>Determine if a woman planning pregnancy is protected against rubella</strong> (for example documentation of having received two doses of rubella-containing vaccine, or a positive antibody test for rubella). Offer measles, mumps, and rubella (MMR) vaccine to seronegative women planning a pregnancy. <ul><li>Note that MMR vaccine should not be given to immunocompromised or pregnant women and women who are not pregnant should avoid pregnancy until one month after administration of the vaccine. For more information on the MMR vaccine, see the chapter on <a href=\"https://www.gov.uk/government/publications/rubella-the-green-book-chapter-28\" data-hyperlink-id=\"0756f2d9-96d3-45d7-bba3-a93100a1b73e\">Rubella</a> in <em>Immunisation against infectious disease</em> (the 'Green Book'), available at <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"93c3fe36-89cb-4633-98e2-a93100a1b75a\">www.gov.uk</a>.</li></ul></li><li><strong>Determine if a woman planning pregnancy has immunity to varicella</strong> (if there is a definite history of chickenpox or herpes zoster, she can be considered to be protected).<ul><li>If there is not a definite history of chickenpox or shingles, and the woman is eligible for the vaccine (for example healthcare workers who come into direct contact with patients; laboratory staff where exposure to varicella virus is an occupational risk; and healthy, susceptible close household contacts of immunocompromised patients), offer serological testing and, if found to be without varicella zoster antibody, offer vaccination.<ul><li>Note that the varicella vaccine should not be given to immunocompromised or pregnant women, and women who are not pregnant should avoid pregnancy until one month after administration of the last dose. For more information on the varicella vaccine, see the chapter on <a href=\"https://www.gov.uk/government/publications/varicella-the-green-book-chapter-34\" data-hyperlink-id=\"b55e9107-067b-425d-b587-a93100a1b75a\">Varicella</a> in <em>Immunisation against infectious disease</em> (the 'Green Book'), available at <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"e610bd2e-1d48-494b-b946-a93100a1b77a\">www.gov.uk</a>.</li></ul></li></ul></li><li><strong>Vaccinate women planning pregnancy against hepatitis B if they are at high risk of contracting the disease.</strong><ul><li>People at risk include intravenous drug users, those who change sexual partners frequently, those with chronic renal or liver disease, and those who are in close contact with people with hepatitis B.</li><li>For more information on the hepatitis B vaccine, see the chapter on <a href=\"https://www.gov.uk/government/publications/hepatitis-b-the-green-book-chapter-18\" data-hyperlink-id=\"b2d57cb9-7b9d-4c26-9535-a93100a1b77a\">Hepatitis B</a> in <em>Immunisation against infectious disease</em> (the 'Green Book'), available at <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"87bd73a8-f688-4fee-af6b-a93100a1b79b\">www.gov.uk</a>.</li></ul></li></ul><!-- end field bc08ad40-64fe-40b3-a06f-373e55ab3e7e --><!-- end item 70f0c118-a7b1-46d0-a041-7227e35c5b8e -->","subChapters":[{"id":"cb04e6da-a68a-56b7-8ecb-5274de9854fe","slug":"basis-for-recommendation-103","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 910e617a-49ea-40fb-a312-c3b74c20a453 --><h4>Basis for recommendation</h4><!-- end field 910e617a-49ea-40fb-a312-c3b74c20a453 -->","summary":null,"htmlStringContent":"<!-- begin item 1038358d-e886-49b6-a633-eebf5e0f2f31 --><!-- begin field f00c5ce8-ab28-4154-a918-131a851386e1 --><h5>Immunization against rubella for non-immune women planning pregnancy</h5><ul><li>The recommendation to confirm protection against rubella is based on <em>Immunisation against infectious disease</em> (the 'Green book'), published by Public Health England, which advises offering MMR vaccine to all seronegative women of childbearing age who require protection against rubella [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2013a</a>].</li><li>Maternal immunity to rubella protects against infection which can cause fetal death or congenital rubella syndrome. This syndrome is most likely when infection occurs in the first 8–10 weeks of pregnancy and includes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2013a</a>]:<ul><li>Cataracts and other eye defects.</li><li>Deafness.</li><li>Cardiac abnormalities.</li><li>Microcephaly.</li><li>Intrauterine growth retardation.</li><li>Inflammatory lesions of brain, liver, lungs, and bone marrow.</li></ul></li></ul><h5>Immunization against varicella for non-immune women planning pregnancy who are eligible for the vaccine</h5><ul><li>The recommendation on determining if a woman planning pregnancy has immunity to varicella is based on information in <em>Immunisation against infectious disease</em> (the 'Green book'), published by Public Health England extrapolation</li><li>CKS recommends immunizing against varicella to prevent:<ul><li>Fetal harms following maternal varicella infection, including [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2015</a>]:<ul><li>In the first 20 weeks of pregnancy, congenital (fetal) varicella syndrome (including limb hypoplasia, microcephaly, cataracts, growth retardation, and skin scarring).</li><li>In the second and third trimesters of pregnancy, herpes zoster may result in an otherwise healthy infant. Occasional cases of fetal damage comprising chorioretinal damage, microcephaly, and skin scarring may result.</li><li>In the last 7 days before, to a week after, delivery, severe and even fatal disease in the neonate.</li></ul></li><li>Maternal harm in the second and third trimester of pregnancy, for example from fulminating varicella pneumonia. Maternal deaths have been reported due to varicella infections between 27 and 32 weeks gestation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2015</a>].</li></ul></li><li><em>Immunisation against infectious disease</em> (the 'Green book') recommends that varicella immunization is restricted to certain groups including healthcare workers who come into direct contact with patients; laboratory staff where exposure to varicella virus is an occupational risk; and healthy, susceptible close household contacts of immunocompromised patients [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2015</a>].</li></ul><h5>Immunization against hepatitis B for women planning pregnancy who are at risk of contracting hepatitis B</h5><ul><li>This recommendation is based on <em>Immunisation against infectious disease</em> (the 'Green book'), which recommends pre-exposure immunization for people at high risk of exposure to the virus because of lifestyle or occupational factors [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016d</a>].<ul><li>Maternal immunization against hepatitis B prevents infection that can be transmitted to the baby perinatally [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016d</a>].</li></ul></li></ul><!-- end field f00c5ce8-ab28-4154-a918-131a851386e1 --><!-- end item 1038358d-e886-49b6-a633-eebf5e0f2f31 -->","subChapters":[]}]},{"id":"796d2049-f6ab-55c4-85b9-cc5f4d1c04b5","slug":"advice-on-zika-virus-infection","fullItemName":"Advice on Zika virus infection","depth":3,"htmlHeader":"<!-- begin field a98ed1b5-e1d3-409d-b70b-761666d4c69c --><h3>What pre-conception advice should I give women about Zika virus infection?</h3><!-- end field a98ed1b5-e1d3-409d-b70b-761666d4c69c -->","summary":null,"htmlStringContent":"<!-- begin item 2188da72-6eb0-4197-b060-bb09c9a2dd6a --><!-- begin field 10e922ae-86ba-47d8-8477-690f203b6b05 --><ul><li>Advise the woman to avoid becoming pregnant during a trip to an area with active Zika virus transmission.</li><li>Advise on mosquito bite avoidance measures day and night (particularly mid-morning and late afternoon to dusk).<ul><li>Public Health England has produced a leaflet on <a href=\"https://www.gov.uk/government/publications/mosquito-bite-avoidance-for-travellers\" data-hyperlink-id=\"32fc7a92-d76c-4876-81db-a93100c7d7ee\">Mosquito bite avoidance for travellers</a>. </li></ul></li><li>Advise that on returning to the UK: <ul><li>If her male partner did not travel, she should avoid conception and consider the use of barrier precautions for 8 weeks from symptom onset or departing a Zika-affected country.</li><li>If her male partner did travel, she should avoid conception and consider the use of barrier precautions for 6 months from symptom onset or departing a Zika-affected country.</li></ul></li><li>For more detailed and updated information, see the Public Health England publications on <a href=\"https://www.gov.uk/government/collections/zika-virus-zikv-clinical-and-travel-guidance#travel-advice\" data-hyperlink-id=\"96b63a52-fcb3-431b-a696-a93100c7d809\">Zika virus</a>, available at <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"1465a1d5-206f-46e7-bfac-a93100c7d80e\">www.gov.uk</a>; or the National Travel Health Network and Centre (NaTHNaC) <a href=\"https://travelhealthpro.org.uk/disease/196/zika-virus\" data-hyperlink-id=\"dea4ba6c-f314-45f0-b555-a93100c7d80e\">Zika virus</a> information, available at <a href=\"http://nathnac.net/\" data-hyperlink-id=\"7af8ecf0-7fce-476e-a16b-a93100c7d91e\">nathnac.net</a>.</li></ul><!-- end field 10e922ae-86ba-47d8-8477-690f203b6b05 --><!-- end item 2188da72-6eb0-4197-b060-bb09c9a2dd6a -->","subChapters":[{"id":"12bb8c8a-f6df-50c0-b48b-82acdc1fd25c","slug":"basis-for-recommendation-25f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ac603615-cfb5-459b-b435-05ed43776511 --><h4>Basis for recommendation</h4><!-- end field ac603615-cfb5-459b-b435-05ed43776511 -->","summary":null,"htmlStringContent":"<!-- begin item 25fc5fac-4f3b-424c-8399-db0d34e9b250 --><!-- begin field 7a57889a-c817-4c12-b368-cc09a13152c1 --><h5>Avoidance of pregnancy during a trip to an area with active Zika virus transmission</h5><ul><li>These recommendations are based on guidelines from Public Health England on <em>Health advice for women returning from areas with active Zika </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016b</a>]; <em>Zika virus infection: guidance for primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016e</a>]; <em>Zika virus: travel advice</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2017a</a>] and <em>Zika: what sexual transmission advice is needed? </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2017b</a>]. </li></ul><h5>Mosquito bite avoidance measures</h5><ul><li>Public Health England recommends mosquito bite avoidance measures for travellers to countries with active Zika virus transmission in the guidance <em>Zika virus: travel advice</em>, because Zika is transmitted by Aedes mosquitoes which usually bite during the day (particularly mid-morning and late afternoon to dusk) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2017a</a>].</li></ul><h5>Advice on returning to the UK regarding delaying pregnancy</h5><ul><li>This recommendation is based on guidelines from Public Health England on <em>Zika virus infection: guidance for primary care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016e</a>]<strong><em> </em></strong>and <em>Zika: what sexual transmission advice is needed?</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2017b</a>].<ul><li>Avoidance of pregnancy is recommended during, and for some time after, travel to a Zika-affected area, because although infection with Zika virus generally causes mild or no symptoms, it can have a severe effect on the developing fetus [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2017a</a>]. There is a consensus that it can cause microcephaly and other congenital abnormalities (congenital Zika syndrome) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">PHE, 2016b</a>]. </li></ul></li></ul><!-- end field 7a57889a-c817-4c12-b368-cc09a13152c1 --><!-- end item 25fc5fac-4f3b-424c-8399-db0d34e9b250 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}